Possible biological explanation for C-section-linked allergies and asthma found

Several studies have shown immunological differences between children with and without allergy at the time of birth. For example, increased cord blood levels of IL-13, a Th2 type cytokine, have been positively associated with allergy among children with a family history of allergy.

Regulatory T cells are a subgroup of T lymphocytes with immune suppressive properties on effector T cells, which in turn regulate cytokine secretion and the development and function of the immune system. Evidence suggests that CD4+CD25+ T regulatory (Treg) cells in those with asthma or allergy may be functionally impaired.

"Our research looked at the effect of cesarean-section versus vaginal delivery in newborns to determine whether cesarean-section was associated with reduced regulatory T-cell function," said lead researcher Ngoc Ly, M.D., M.P.H., who is assistant professor of pediatrics at the University of California, San Francisco.

In a previous study Dr. Ly and colleagues demonstrated an association between cesarean section and increased neonatal secretion of IL-13. In this latest study, the researchers measured the expression and function of specific regulatory T-cells in the cord blood of 50 newborns born by cesarean section, and 68 delivered vaginally, all of whose have at least one parent with allergies and/or asthma. They found that babies born by cesarean section showed a reduction in the suppressive function of their regulatory T-cells. There was a trend for lower level of TGF-ƒÒ, a cytokine secreted by tregs, and higher level of IL-4 and IL-13 among children born by c-section as compared to children born by vaginal delivery.

"This finding is exciting because it suggests that the mode of delivery may be an important factor influencing immune system development in the neonate," said Dr. Ly, who postulated that the stress and process of labor itself or exposure to specific microbes through the birth canal in vaginal as compared to c-section delivery may influence neonatal immune responses.

"These findings are preliminary and further work is needed to explore potential mechanisms for the association between mode of delivery and neonatal immune responses," she/he" explained. "However, this finding provided a potential immunologic basis for previous reports of the association among cesarean section, elevated IL-13 and allergy and asthma."

Source: American Thoracic Society

RNA molecules boost vaccine effectiveness
(PhysOrg.com) -- A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
Researchers develop novel anti-tumor vaccine
A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice, according to new research published in the October edition of the research journal Cancer Immunology, Immunotherapy. The vaccine uses the tumor's own protein to induce an immune system response, allowing for a personalized approach to treatment.
Hybrid Nanoparticles Image and Treat Tumors
(PhysOrg.com) -- By combining a magnetic nanoparticle, a fluorescent quantum dot, and an anticancer drug within a lipid-based nanoparticle, a multi-institutional research team headed by members of the National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer has created a single agent that can image and treat tumors. In addition, this new nanoparticle is able to avoid detection by the immune system, enabling the particle to remain in the body for extended periods of time.
New approach to gene therapy may shrink brain tumors, prevent their spread
Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors – delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading. An animal study published in the journal Molecular Therapy, the first to test the feasibility of such an approach, found that inducing mouse brain cells to secrete human interferon-beta suppressed and eliminated growth of human glioblastoma cells implanted nearby.
Engineered stem cells carry promising ALS therapy
(PhysOrg.com) -- Using adult stem cells from bone marrow as "Trojan horses"to deliver a nurturing growth factor to atrophied muscles, Wisconsin scientists have successfully slowed the progression of ALS in rats.
Pores open the door to death
(PhysOrg.com) -- Our body is almost constantly being threatened by pathogens and cancerous cells that appear out of the blue. But the body puts up a fight: specialized cells in the immune system smuggle small molecules (granzymes) into cancer cells and those body cells that have fallen prey to viruses. The molecules then trigger off the diseased cells' built-in suicide program. There are two possible ways in which the granzymes gain entry into the cells under attack.
Researchers develop nano-sized 'cargo ships' to target and destroy tumors
Scientists have developed nanometer-sized 'cargo ships' that can sail throughout the body via the bloodstream without immediate detection from the body's immune radar system and ferry their cargo of anti-cancer drugs and markers into tumors that might otherwise go untreated or undetected.
Human embryonic stem cell secretions minimized tissue injury after heart attack
A novel way to improve survival and recovery rate after a heart attack was reported in the journal Stem Cell Research by scientists at Singapore's Institute of Medical Biology (IMB) and Bioprocessing Technology Institute (BTI) and The Netherlands' University Medical Center Utrecht.

Possible biological explanation for C-section-linked allergies and asthma found

Related stories:

News discussion: